Validation of COPD Population Screener Questionnaire in Chinese Population : A National Multicenter Study
© 2023 S. Karger AG, Basel..
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is highly prevalent and underdiagnosed worldwide. The validity and reliability of COPD Population Screening (COPD-PS) questionnaire are not properly known in a large-sample Chinese population.
METHODS: This is a national multicenter prospective study that enrolled 1,824 outpatients from 12 hospital sites in China. Scores of the Chinese version of COPD-PS questionnaire, demographic data, and clinical information were collected. The validity and the test-retest reliability were evaluated.
RESULTS: 1,824 participants were involved in this study, and 404 (22.1%) were diagnosed with COPD. The overall area under the curve (AUC) of the receiver operating characteristic (ROC) for COPD-PS questionnaire was 0.761 (95% CI: 0.734-0.787). A cut-off point of 4 was recommended, corresponding to a sensitivity of 74.50% and a specificity of 64.37%. The COPD-PS questionnaire showed an overall Pearson's correlation of 0.88.
CONCLUSIONS: The COPD-PS questionnaire can be used in screening COPD patients from the general Chinese population with respiratory symptoms.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:102 |
---|---|
Enthalten in: |
Respiration; international review of thoracic diseases - 102(2023), 12 vom: 05., Seite 995-1002 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhan, Zijie [VerfasserIn] |
---|
Links: |
---|
Themen: |
COPD-PS |
---|
Anmerkungen: |
Date Completed 20.12.2023 Date Revised 20.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1159/000535368 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365397105 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365397105 | ||
003 | DE-627 | ||
005 | 20231227134900.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1159/000535368 |2 doi | |
028 | 5 | 2 | |a pubmed24n1233.xml |
035 | |a (DE-627)NLM365397105 | ||
035 | |a (NLM)38048758 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhan, Zijie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Validation of COPD Population Screener Questionnaire in Chinese Population |b A National Multicenter Study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.12.2023 | ||
500 | |a Date Revised 20.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 S. Karger AG, Basel. | ||
520 | |a INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is highly prevalent and underdiagnosed worldwide. The validity and reliability of COPD Population Screening (COPD-PS) questionnaire are not properly known in a large-sample Chinese population | ||
520 | |a METHODS: This is a national multicenter prospective study that enrolled 1,824 outpatients from 12 hospital sites in China. Scores of the Chinese version of COPD-PS questionnaire, demographic data, and clinical information were collected. The validity and the test-retest reliability were evaluated | ||
520 | |a RESULTS: 1,824 participants were involved in this study, and 404 (22.1%) were diagnosed with COPD. The overall area under the curve (AUC) of the receiver operating characteristic (ROC) for COPD-PS questionnaire was 0.761 (95% CI: 0.734-0.787). A cut-off point of 4 was recommended, corresponding to a sensitivity of 74.50% and a specificity of 64.37%. The COPD-PS questionnaire showed an overall Pearson's correlation of 0.88 | ||
520 | |a CONCLUSIONS: The COPD-PS questionnaire can be used in screening COPD patients from the general Chinese population with respiratory symptoms | ||
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COPD-PS | |
650 | 4 | |a Chronic obstructive pulmonary disease | |
650 | 4 | |a Questionnaire | |
650 | 4 | |a Validation | |
700 | 1 | |a Ma, Yiming |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yahong |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jing |e verfasserin |4 aut | |
700 | 1 | |a Li, Wen |e verfasserin |4 aut | |
700 | 1 | |a He, Zhiyi |e verfasserin |4 aut | |
700 | 1 | |a Xie, Jungang |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Haijin |e verfasserin |4 aut | |
700 | 1 | |a Xu, Anping |e verfasserin |4 aut | |
700 | 1 | |a Peng, Kun |e verfasserin |4 aut | |
700 | 1 | |a Wang, Gang |e verfasserin |4 aut | |
700 | 1 | |a Zeng, Qingping |e verfasserin |4 aut | |
700 | 1 | |a Yang, Ting |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Chen |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Respiration; international review of thoracic diseases |d 1968 |g 102(2023), 12 vom: 05., Seite 995-1002 |w (DE-627)NLM000076384 |x 1423-0356 |7 nnns |
773 | 1 | 8 | |g volume:102 |g year:2023 |g number:12 |g day:05 |g pages:995-1002 |
856 | 4 | 0 | |u http://dx.doi.org/10.1159/000535368 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 102 |j 2023 |e 12 |b 05 |h 995-1002 |